These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25807931)

  • 1. Letter to the editor by the authors of Exact Calculation of Power and Sample Size in Bioequivalence Studies Using Two One-sided Tests, Pharmaceutical Statistics, DOI: 10.1002/pst.1666.
    Shen M; Russek-Cohen E; Slud EV
    Pharm Stat; 2015; 14(3):272. PubMed ID: 25807931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exact calculation of power and sample size in bioequivalence studies using two one-sided tests.
    Shen M; Russek-Cohen E; Slud EV
    Pharm Stat; 2015; 14(2):95-101. PubMed ID: 25477145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size determination for equivalence assessment with multiple endpoints.
    Sun A; Dong X; Tsong Y
    J Biopharm Stat; 2014; 24(6):1203-14. PubMed ID: 25032845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equivalence assessment for interchangeability based on two-sided tests.
    Dong X; Tsong Y
    J Biopharm Stat; 2014; 24(6):1312-31. PubMed ID: 25032976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro bioequivalence testing.
    Chow SC; Shao J; Wang H
    Stat Med; 2003 Jan; 22(1):55-68. PubMed ID: 12486751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An approach for sample size determination of average bioequivalence based on interval estimation.
    Chiang C; Hsiao CF
    Stat Med; 2017 Mar; 36(7):1068-1082. PubMed ID: 28070984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exact Power and Sample Size Calculations for the Two One-Sided Tests of Equivalence.
    Shieh G
    PLoS One; 2016; 11(9):e0162093. PubMed ID: 27598468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An approximate approach to sample size determination in bioequivalence testing with multiple pharmacokinetic responses.
    Tsai CA; Huang CY; Liu JP
    Stat Med; 2014 Aug; 33(19):3300-17. PubMed ID: 24771655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incurred sample reanalysis in bioequivalence studies for abbreviated new drug applications.
    Subramaniam S; Stier E; Davit BM
    Bioanalysis; 2014; 6(24):3349-54. PubMed ID: 25534791
    [No Abstract]   [Full Text] [Related]  

  • 10. A simple formula for sample size calculation in equivalence studies.
    Zhang P
    J Biopharm Stat; 2003 Aug; 13(3):529-38. PubMed ID: 12921399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample sizes for batch acceptance from single- and multistage designs using two-sided normal tolerance intervals with specified content.
    Hauck WW; Shaikh R
    J Biopharm Stat; 2001 Nov; 11(4):335-46. PubMed ID: 12018783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A note on power and sample size calculations for the Kruskal-Wallis test for ordered categorical data.
    Fan C; Zhang D
    J Biopharm Stat; 2012; 22(6):1162-73. PubMed ID: 23075015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality assurance test of delivered dose uniformity of multiple-dose inhaler and dry powder inhaler drug products.
    Tsong Y; Dong X; Shen M; Lostritto RT
    J Biopharm Stat; 2015; 25(2):328-38. PubMed ID: 25357132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modified large sample approach in the assessment of population bioequivalence.
    Quiroz J; Ting N; Wei GC; Burdick RK
    J Biopharm Stat; 2000 Nov; 10(4):527-44. PubMed ID: 11104391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equivalence tests for interchangeability based on two one-sided probabilities.
    Dong X; Tsong Y; Shen M
    J Biopharm Stat; 2014; 24(6):1332-48. PubMed ID: 25033074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tests for individual and population bioequivalence based on generalized p-values.
    McNally RJ; Iyer H; Mathew T
    Stat Med; 2003 Jan; 22(1):31-53. PubMed ID: 12486750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the reference scaled bioequivalence semi-replicate method with other approaches: focus on human exposure to drugs.
    Karalis V; Symillides M; Macheras P
    Eur J Pharm Sci; 2009 Aug; 38(1):55-63. PubMed ID: 19524039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of the computational procedure in Parker and Bregman's method of calculating sample size from matched case-control studies with a dichotomous exposure.
    Novikov I; Oberman B; Freedman L
    Biometrics; 2005 Dec; 61(4):1123-6; discussion 1126-7. PubMed ID: 16401288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimmed weighted Simes' test for two one-sided hypotheses with arbitrarily correlated test statistics.
    Brannath W; Bretz F; Maurer W; Sarkar S
    Biom J; 2009 Dec; 51(6):885-98. PubMed ID: 20014203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viewpoint: observations on scaled average bioequivalence.
    Patterson SD; Jones B
    Pharm Stat; 2012; 11(1):1-7. PubMed ID: 22162308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.